Company snapshot
Market Cap
$49B
Large-cap2016 — today
10-Year Price
+41%
2016 — today
52-Week Range
$138.67$192.00
Current $177.85· 73%
Featured in rankings
Dividend KingsS&P500Dividend AristocratsMost Undervalued Healthcare StocksBest Healthcare Dividend StocksMost Undervalued Value StocksMost Undervalued Dividend StocksMost Undervalued Growth StocksCheapest Large-Cap Stocks
Rankings recomputed after each US market close — see where BDX stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| EWEdwards Lifesciences Corporation | 48.5 | — |
| HUMHumana Inc. | 38.8 | 0.9% |
| NTRANatera, Inc. | -241.9 | — |
| TEVATeva Pharmaceutical Industries Limited | 61.8 | — |
| CAHCardinal Health, Inc. | 32.4 | 0.9% |
| RVMDRevolution Medicines, Inc. | -23.0 | — |
| AAgilent Technologies, Inc. | 28.9 | 0.5% |
| TAKTakeda Pharmaceutical Company Limited | 49.6 | 3.4% |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
53.6
Historically pricey
Historically pricey — last 10 years
Sector median 24.4above sector
P/B ratio
2.0
Historically cheap
Historically cheap relative to the last 10 years
Sector median 2.5below sector
EV / EBITDA
16.7
Above average
Pricier than usual over the last 10 years
Sector median 15.2above sector
Dividend Yield
2.2%
Historically high
Historically high relative to the last 10 years
Sector median 1.7%above sector
FCF Yield
5.3%
Above average
Above the 10-year average
Sector median -9.6%above sector